Moreover, using [35S]GTPgammaS binding assays which assesses coupling of G-proteins to G-protein-coupled receptors in postmortem brain, the authors found that CB1 cannabinoid signaling was increased in the same region when compared to healthy controls (238) implicating cannabinoid signaling in both depression and suicide. The gene discussed is CNR1; the disease is depressive symptom measurement.